The transcriptional repressor BLIMP1 enforces TCF-1-dependent and -independent restriction of the memory fate of CD8+ T cells.

Saved in:
Bibliographic Details
Title: The transcriptional repressor BLIMP1 enforces TCF-1-dependent and -independent restriction of the memory fate of CD8+ T cells.
Authors: Murphy MK; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., McCullen M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, OH, USA., Deffenbaugh JL; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., Chen AY; Department of Pathology, Stanford University, Stanford, CA, USA; Department of Bioengineering, Stanford University, Stanford, CA, USA., Pai J; Department of Pathology, Stanford University, Stanford, CA, USA; Department of Immunology, Stanford University, Stanford, CA, USA., Daniel B; Department of Pathology, Stanford University, Stanford, CA, USA., Yousif A; Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, OH, USA., Raju S; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., Hsiung S; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., Wang Z; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., Ghoneim HE; Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, OH, USA; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Satpathy AT; Department of Pathology, Stanford University, Stanford, CA, USA; Department of Bioengineering, Stanford University, Stanford, CA, USA; Department of Immunology, Stanford University, Stanford, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Colonna M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., Oltz EM; Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, OH, USA; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Egawa T; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: egawat@wustl.edu.
Source: Immunity [Immunity] 2025 Oct 14; Vol. 58 (10), pp. 2472-2488.e9. Date of Electronic Publication: 2025 Oct 02.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-4180
DOI:10.1016/j.immuni.2025.09.008